Skip to main content
SpringerLink
Log in

Development and Validation of the Chiral HPLC Method for Daclatasvir in Gradient Elution Mode on Amylose-Based Immobilized Chiral Stationary Phase

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A selective and specific high-performance liquid chromatography method for the determination of daclatasvir enantiomers has been developed and validated. Various immobilized polysaccharide-based chiral stationary phases were used to define a separation strategy utilizing normal-phase and polar organic chromatography modes. Excellent resolution between daclatasvir and its enantiomer was achieved on amylose tris (3-chlorophenylcarbamate) stationary phase, namely CHIRALPAK ID-3, using binary gradient containing acetonitrile:diethylamine and methanol:diethylamine as the mobile phase. The flow rate of the mobile phases was maintained at 1.0 mL min−1 while the column oven temperature was maintained at 40 °C. The column effluent was monitored by UV detection at 315 nm. In comparison with isocratic method, the binary gradient method offered excellent peak shape and improved resolution between daclatasvir and its enantiomer while maintaining the specificity with diastereomers. The method was found to be precise, accurate, and linear (R 2 > 0.999). Limit of detection and limit of quantitation of the enantiomer were found to be 0.083 µg mL−1 as and 0.25 µg mL−1, respectively. Recovery of the enantiomer was found to be in the range of 90 to 112 %.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Adam R, McMaster P, O’Grady JG, Castaing D, Klempnauer JL, Jamieson N, Neuhaus P, Lerut J, Salizzoni M, Pollard S (2003) Liver Transpl 9:1231–1243

    Article  Google Scholar 

  2. Kim W (2002) J Hepatol 36:S30–S34

    Article  Google Scholar 

  3. Berenguer M, Schuppan D (2013) J Hepatol 58:1028–1041

    Article  CAS  Google Scholar 

  4. Pellicelli AM, Montalbano M, Lionetti R, Durand C, Ferenci P, D’Offizi G, Knop V, Telese A, Lenci I, Andreoli A, Zeuzem G, Angelico M (2014) Dig Liver Dis 46:923–927

    Article  CAS  Google Scholar 

  5. Sulkowski MS, Gardiner DF, Rodriguez-Torres M, Reddy KR, Hassanein T, Jacobson I, Lawitz E, Lok AS, Hinestrosa F (2014) PThuluvath PJ. New Engl J Med 370:211–221

    Article  CAS  Google Scholar 

  6. Pol S, Ghalib RH, Rustgi VK, Martorell C, Everson GT, Tatum HA, Hézode C, Lim JK, Bronowicki JP, Abrams GA (2012) Lancet infect Dis 12:671–677

    Article  CAS  Google Scholar 

  7. Asselah T (2014) J Hepatol 61:435–438

    Article  CAS  Google Scholar 

  8. Bartolini B, Lionetti R, Giombini E, Sias C, Taibi C, Montalbano M, McPhee F, Hughes EA, Zhou N, Ippolito G (2015) J Clin Virol 66:38–43

    Article  CAS  Google Scholar 

  9. Bifano M, Adamczyk R, Hwang C, Kandoussi H, Marion A, Bertz RJ (2015) Clin Drug Invest 35:281–289

    Article  CAS  Google Scholar 

  10. Nelson DR, Cooper JN, Lalezari JP, Lawitz E, Pockros PJ, Gitlin N, Freilich BF, Younes ZH, Harlan W, Ghalib R (2015) Hepatology 61:1127–1135

    Article  CAS  Google Scholar 

  11. Barakat KH, Anwar-Mohamed A, Tuszynski JA, Robins MJ, Tyrrell DL, Houghton M (2014) J Chem Inform Model 55:362–373

    Article  Google Scholar 

  12. McCormack PL (2015) Drugs 75:515–524

    Article  CAS  Google Scholar 

  13. Kumada H, Suzuki Y, Ikeda K, Toyota J, Karino Y, Chayama K, Kawakami Y, Ido A, Yamamoto K, Takaguchi K (2014) Hepatology 59:2083–2091

    Article  CAS  Google Scholar 

  14. Yuan L, Jiang H, Zheng N, Xia Y-Q, Ouyang Z, Zeng J, Akinsanya B, Valentine JL, Moehlenkamp JD, Deng Y (2014) J Chromatogr B 973:1–8

    Article  CAS  Google Scholar 

  15. Mamdouh RR, Ehab RB, Emad BB, Iman AK (2016) J Pharm Biomed Anal 128:61–66

    Article  Google Scholar 

  16. Jiang H, Kandoussi H, Zeng J, Wang J, Demers R, Eley T, He B, Burrell R, Easter J, Kadiyala P (2015) J Pharm Biomed Anal 107:409–418

    Article  CAS  Google Scholar 

  17. Miura M, Maekawa S, Sato M, Komatsu N, Tatsumi A, Takano S, Amemiya F, Nakayama Y, Inoue T, Sakamoto M (2014) Hepatology Research 44:E360–E367

    Article  CAS  Google Scholar 

  18. Tong Z, Dung N, Pilar F (2008) J Chromatogr A 1191:214–222

    Article  Google Scholar 

  19. Pilar F, Tong Z (2008) J Chromatography B 875:48–56

    Article  Google Scholar 

  20. Morante-Zarcero S, Sierra I (2012) J Pharm Biomed Anal 62:33–41

    Article  CAS  Google Scholar 

  21. United States Pharmacopeia XXIII, p 1982

Download references

Acknowledgments

The authors thank the management of Daicel Chiral Technologies India for supporting this work. We also thank Mr. Chandrasekhar, Sr. Research Associate, Daicel Chiral Technologies India, for his assistance in carrying out this work.

Author information

Authors and Affiliations

  1. Daicel Chiral Technologies (India) Pvt Ltd, IKP Knowledge Park, Hyderabad, 500078, India

    G. Srinivasu, K. Nagesh Kumar, Ch. Thirupathi & Ch. Lakshmi Narayana

  2. Department of Chemistry, Osmania University, Hyderabad, 500007, India

    Ch. Parameswara Murthy

Authors
  1. G. Srinivasu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Nagesh Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ch. Thirupathi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ch. Lakshmi Narayana
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ch. Parameswara Murthy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Srinivasu.

Ethics declarations

Conflict of interest

G. Srinivasu declares that he has no conflict of interest. K. Nagesh Kumar declares that he has no conflict of interest. Ch. Thirupathi declares that he has no conflict of interest. Ch. Lakshmi Narayana declares that he has no conflict of interest. Ch. Parameswara Murthy declares that he has no conflict of interest.

Research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Srinivasu, G., Kumar, K.N., Thirupathi, C. et al. Development and Validation of the Chiral HPLC Method for Daclatasvir in Gradient Elution Mode on Amylose-Based Immobilized Chiral Stationary Phase. Chromatographia 79, 1457–1467 (2016). https://doi.org/10.1007/s10337-016-3157-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-016-3157-2

Keywords

Search

Navigation